REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/01/2026
Voltar para busca
Dado oficial do USPTO
MIDASOLVE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
MIDASOLVE
ST13
US500000079265537Classe
1, 5, 40, 42
Pedido
79265537
Registro
6235759
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
35
Atualização mais recente
06/01/2026
Tipo de marca
Verbal
Classes Nice
1, 5, 40, 42
Data de depósito
28/05/2019
Data de registro
05/01/2021
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
05/01/2021
Última transação
06/01/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
GB
Examinador
FLETCHER,TRACY L
Unidade examinadora
M60
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Midatech Limited
Representantes
Manuel Valcarcel, Esq. Greenberg Traurig, P.A.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 40Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Nano-particle ingredientsnanoparticle chemical compounds for use in the manufacture of pharmaceuticalsmedicines and cosmetics; macrocylic chemicals used as solubilising and stabilising agents for use in manufacturing pharmaceuticalsmedicines and cosmetics
Classe 5
Pharmaceuticals and medicines containing nano-particles for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatricimmune system and central nervous system related diseases and disorders; vaccines incorporating nano-particles; drug delivery agents consisting of compounds that facilitate the delivery of pharmaceuticals and medicines; nano-particles for use as carriers sold as an integral component of pharmaceutical preparations and medicines for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatricimmune system and central nervous system related diseases and disorders; nano-particles for use as carriers sold as an integral component of medicated cosmetics
Classe 40
Custom manufacture of nano-particles; custom manufacture of pharmaceuticals and medicines containing nano-particles; custom manufacture of nano-particle devices to the order and specification of others; custom manufacture of drug delivery agents for facilitating delivery of pharmaceuticals and medicines; custom manufacture of macrocylic compoundscompositions and derivates used as solubilising and stabilising agents for use in further manufacture of pharmaceuticalsmedicines and cosmetics
Classe 42
Scientific research services in the field of nano-particle technology; pharmaceutical and drug researchdevelopment and discovery services; drug delivery agent researchdevelopment and discovery services; testing and advisory services related to research and product design in the field of nano-particlesmacro-cyclic compoundspharmaceuticals and nano-medicine; nano-particle laboratory research services
Publicações
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/05/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/04/2021
FIMP
FINAL DISPOSITION PROCESSED
12/04/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/04/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
05/01/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
20/10/2020
PUBO
PUBLISHED FOR OPPOSITION
20/10/2020
GPNX
NOTIFICATION PROCESSED BY IB
18/10/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
30/09/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
30/09/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
30/09/2020
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
18/09/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/09/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/09/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/09/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
11/09/2020
GNS1
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
27/03/2020
GNSF
SUBSEQUENT FINAL EMAILED
27/03/2020
CFRC
SUBSEQUENT FINAL REFUSAL WRITTEN
27/03/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
26/03/2020
GNFR
FINAL REFUSAL E-MAILED
26/03/2020
CNFR
FINAL REFUSAL WRITTEN
26/03/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/03/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/03/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/03/2020
RFNT
REFUSAL PROCESSED BY IB
05/10/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
13/09/2019
RFRR
REFUSAL PROCESSED BY MPU
13/09/2019
MAFR
APPLICATION FILING RECEIPT MAILED
03/09/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/09/2019
CNRT
NON-FINAL ACTION WRITTEN
31/08/2019
DOCK
ASSIGNED TO EXAMINER
30/08/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
30/08/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
22/08/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MIDASOLVE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.